|
|
The relationship of 12 candidate single nucleotide polymorphisms with susceptibility and prognosis of acute lymphoblastic leukemia in Chinese children |
WANG Zhen1, WU Ruichi2, MO Yixiao1, CHEN Jing2, TANG Yanjing2, SHEN Shuhong1, 2. |
1.Department of Hematology, the Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 325027, China; 2.Department of Hematology and Oncology,Shanghai Children’s Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China |
|
|
Abstract Objective: To investigate the relationship of 12 candidate single nucleotide polymorphisms(SNP) loci with the susceptibility and prognosis of Chinese children with acute lymphoblastic leukemia (ALL).Methods: Review the literature and select 12 candidate SNP loci, and then detect the genotype of each SNP by multiplex PCR targeted capture next-generation sequencing technology. A case-control study on 556 children with ALL and 191 healthy volunteers was conducted using chi-square test and logistic regression analysis to verify the relationship between SNP loci and the susceptibility of Chinese children with ALL. Kaplan-Meier survival analysis and Cox regression were used to analyze the relationship between SNP loci and the prognosis of ALL in 365 ALL cases. Results: Logistic regression analysis showed that the genotype of the SNP locus was significantly correlated with the increased risk of ALL: the rs10821936 risk allele C (OR=1.687, 95%CI=1.318-2.135, P<0.001) and rs10994982 risk allele A (OR=1.594, 95%CI=1.259-2.018, P<0.001) of the ARID5B gene;rs11978267 risk allele G (OR=2.133, 95%CI=1.495-3.043, P<0.001) and rs4132601 risk allele G (OR=2.108,95%CI=1.466-3.031, P<0.001) of the IKZF1 gene and the rs7554607 risk allele C (OR=1.481, 95%CI=1.161-1.890, P=0.002) of the ZNF230 gene. Multivariate Cox regression analysis showed that the following were an poor prognostic factor of event-free survival rate: TC genotype at rs10873876 locus of SIAT7C gene (HR=2.111,95%CI=1.260-3.539, P=0.005) and GG genotype at rs11155133 locus of LOC102723724 gene (HR=4.787,95%CI=1.652-13.870, P=0.004). At the same time, they were also poor prognostic factors of recurrence rate (the former HR=2.082, 95%CI=1.242-3.492, P=0.005, the latter HR=4.067, 95%CI=1.380-11.988, P=0.011).Conclusion: The rs10821936 and rs10994982 of ARID5B gene, rs7554607 of ZNF230 gene, rs11978267 and rs4132601 of IKZF1 gene are the potential susceptibility loci of ALL in Chinese children. Polymorphism loci of rs10873876 of SIAT7C and rs11155133 of LOC102723724 can be prognostic factors for childhood ALL.
|
Received: 11 November 2020
|
|
|
|
|
[1] HUNGER S P, MULLIGHAN C G. Acute lymphoblastic leukemia in children[J]. N Engl J Med, 2015, 373(16): 1541-1552.
[2] PUI C H, EVANS W E. Treatment of acute lymphoblastic leukemia[J]. N Engl J Med, 2006, 354(2): 166-178.
[3] LINABERY A M, ROSS J A. Trends in childhood cancer incidence in the U.S. (1992-2004)[J]. Cancer, 2008, 112(2):416-432.
[4] VROOMAN L M, SILVERMAN L B. Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances[J]. Curr Hematol Malig Rep, 2016,11(5): 385-394.
[5] SHEN S,CAI J, CHEN J, et al. Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China[J]. Hematol Oncol, 2018, 36(4): 679-688.
[6] BELSON M, KINGSLEY B, HOLMES A. Risk factors for acute leukemia in children: a review[J]. Environ Health Perspect, 2007, 115(1): 138-145.
[7] PAPAEMMANUIL E, HOSKING F J, VIJAYAKRISHNAN J,et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia [J]. Nat Genet, 2009, 41(9): 1006-1010.
[8] TREVIÑO L R,YANG W, FRENCH D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia[J]. Nat Genet, 2009, 41(9): 1001-1005.
[9] WANG Y, CHEN J, LI J, et al. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population[J]. Gene, 2013, 524(2): 203-207.
[10] TAO R, LIU Y J, LIU L F, et al. Genetic polymorphisms of ARID5B rs7089424 and rs10994982 are associated with Blineage ALL susceptibility in Chinese pediatric population[J]. J Chin Med Assoc, 2019, 82(7): 562-567.
[11] 莫一啸, 王桢, 王盼, 等. 12个单核苷酸多态性位点与儿童急性淋巴细胞白血病易感性的关系[J]. 温州医科大学学报, 2021, 51(1): 1-7.
[12] ROCHA J C, CHENG C, LIU W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia[J].Blood, 2005, 105(12): 4752-4758.
[13] KODIDELA S, PRADHAN S C, DUBASHI B, et al.Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767(-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia[J].Eur J Clin Pharmacol, 2015, 71(11): 1349-1358.
[14] ANSARI M, SAUTY G, LABUDA M, et al. Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia[J]. Blood, 2009, 114(7): 1383-1386.
[15] GREGERS J, GRéEN H, CHRISTENSEN I J, et al.Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia[J].Pharmacogenomics J, 2015, 15(4): 372-379.
[16] LI H, DURBIN R. Fast and accurate short read alignment with Burrows-Wheeler transform[J]. Bioinformatics, 2009,25(14): 1754-1760.
[17] LI H, HANDSAKER B, WYSOKER A, et al. The Sequence Alignment/Map format and SAMtools[J]. Bioinformatics,2009, 25(16): 2078-2079.
[18] WANG K, LI M, HAKONARSON H. ANNOVAR:functional annotation of genetic variants from highthroughput sequencing data[J]. Nucleic Acids Res, 2010,38(16): e164.
[19] MOSAAD Y M, EL-ZINY M A, DARWISH A, et al. IKZF1 rs4132601 and rs11978267 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome[J]. J Pediatr Hematol Oncol, 2020, 42(7): 420-428.
[20] YANG J J, CHENG C, YANG W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia[J]. JAMA, 2009, 301(4): 393-403.
[21] XU H, CHENG C, DEVIDAS M, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia[J]. J Clin Oncol, 2012, 30(7): 751-757.
[22] MOSAAD Y M, KHASHABA M, DARWISH A, et al.ARID5B rs10821936 and rs10994982 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome[J]. Pediatr Hematol Oncol, 2019,36(6): 365-375.
[23] MULLIGHAN C G, MILLER C B, RADTKE I, et al. BCRABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros[J]. Nature, 2008, 453(7191): 110-114.
[24] BIELSKA M, BOROWIEC M, JESIONEK-KUPNICKA D,et al. Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma[J]. Int J Hematol, 2017,106(6): 794-800.
[25] ZHAO Y, LI Y, MA H, et al. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma[J]. Mol Cell Proteomics,2014, 13(2): 520-536.
[26] SCHULTZ M J, SWINDALL A F, WRIGHT J W, et al.ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells[J]. J Ovarian Res, 2013, 6(1): 25.
[27] LIU Q, MA H, SUN X, et al. The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia[J]. J Exp Clin Cancer Res, 2019, 38(1): 199.
[28] LAMMENS T, DURINCK K, WALLAERT A, et al. Long non-coding RNAs in leukemia: biology and clinical impact[J]. Curr Opin Hematol, 2017, 24(4): 353-358.
[29] ALVAREZ-DOMINGUEZ J R, LODISH H F. Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis[J]. Blood, 2017, 130(18):1965-1975.
[30] DE LA ROSA R, VILLEGAS-RUÍZ V, CABALLEROPALACIOS M C, et al. Expression of ZNF695 transcript variants in childhood B-cell acute lymphoblastic leukemia[J]. Genes (Basel), 2019, 10(9): 716.
[31] BÁRCENAS-LÓPEZ D A, NÚÑEZ-ENRíQUEZ J C,HIDALGO-MIRANDA A, et al. Transcriptome analysis identifies LINC00152 as a biomarker of early relapse and mortality in acute lymphoblastic leukemia[J]. Genes (Basel),2020, 11(3): 302. |
|
|
|